Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Revenue

Innovita Biological Technology had revenue of 108.81M CNY in the quarter ending March 31, 2026, a decrease of -47.43%. This brings the company's revenue in the last twelve months to 323.87M, down -40.76% year-over-year. In the year 2025, Innovita Biological Technology had annual revenue of 422.03M, down -32.08%.

• Revenue (ttm): 323.87M
• Revenue Growth: -40.76%
• P/S Ratio: 23.91
• Revenue / Employee: 567.21K
• Employees: 558
• Market Cap: 7.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	422.03M	-199.36M	-32.08%
Dec 31, 2024	621.39M	143.37M	29.99%
Dec 31, 2023	478.02M	31.40M	7.03%
Dec 31, 2022	446.62M	119.71M	36.62%
Dec 31, 2021	326.91M	-710.19M	-68.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error